Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
Melatonin Boosts DNA Repair in Night Shift Workers by 80% in New TrialLongevity & Aging

Melatonin Boosts DNA Repair in Night Shift Workers by 80% in New Trial

A new clinical trial published in Occupational & Environmental Medicine found that melatonin supplements may help night shift workers repair DNA damage caused by overnight work. Forty workers were randomly assigned to take 3mg of melatonin or a placebo daily for four weeks, consumed about an hour before daytime sleep. Researchers measured urinary levels of 8-OHdG, a biomarker reflecting oxidative DNA repair activity. Workers taking melatonin showed 80% higher 8-OHdG levels during daytime sleep compared to the placebo group, suggesting enhanced DNA repair. Night shift work is known to suppress natural melatonin production and impair the body's ability to fix oxidative DNA damage, a process linked to elevated cancer risk. Researchers caution that larger trials are needed before melatonin can be formally recommended.

Deep Dive Audio
0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.